About
Small Molecule
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Team (13)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
729
By Phase
PHASE2: 1PHASE2/PHASE3: 1PHASE1: 2
By Status
RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06059118Collaborator
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
PHASE2Recruiting
50 participants
Started: Oct 4, 2023 · Completed: Nov 30, 2029
NCT05254171Lead Sponsor
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
PHASE2/PHASE3Recruiting
600 participants
Started: Aug 8, 2022 · Completed: Jan 1, 2027
NCT03412799Lead Sponsor
Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
PHASE1Completed
50 participants
Started: Jun 4, 2018 · Completed: Feb 28, 2022
NCT02657330Lead Sponsor
Study of SBP-101 in Pancreatic Cancer
PHASE1Completed
29 participants
Started: Jan 31, 2016 · Completed: Oct 31, 2017
Locations (1)
Headquarters
Waconia, MN, United States
Map
Loading map...